相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
O. Van der Meeren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
Francesca Micoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Vaccine candidates for poor nations are going to waste
David C. Kaslow et al.
NATURE (2018)
Technologies to address antimicrobial resistance
Stephen J. Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
Dimitrios Gouglas et al.
LANCET GLOBAL HEALTH (2018)
Multivalent and Multipathogen Viral Vector Vaccines
Katharina B. Lauer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Ebola vaccines in clinical trial: The promising candidates
Yuxiao Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Mechanism of action of mRNA-based vaccines
Carlo Iavarone et al.
EXPERT REVIEW OF VACCINES (2017)
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)
Ana Maria Henao-Restrepo et al.
LANCET (2017)
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data
Caroline L. Trotter et al.
LANCET INFECTIOUS DISEASES (2017)
Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
Olga De Santis et al.
LANCET INFECTIOUS DISEASES (2016)
Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
Olubukola T. Idoko et al.
CLINICAL INFECTIOUS DISEASES (2015)
Perils of launching a new vaccination campaign
Frank Dobson
BMJ-BRITISH MEDICAL JOURNAL (2014)
Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics
Philip R. Dormitzer et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV) Lessons from past programs and implications for the future
Johan Holst et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
Armin Hekele et al.
EMERGING MICROBES & INFECTIONS (2013)
200 NEJM ANNIVERSARY ARTICLE The Perpetual Challenge of Infectious Diseases
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
High Yield Production Process for Shigella Outer Membrane Particles
Francesco Berlanda Scorza et al.
PLOS ONE (2012)
Estimated research and development costs of rotavirus vaccines
Donald W. Light et al.
VACCINE (2009)
Meningococcal C conjugate vaccine: The experience in England and Wales
Helen Campbell et al.
VACCINE (2009)
分享论文
